and that those whose insurance doesn’t cover the drug can get $500 off its $1,350 list price for up to a year. As with Wegovy ...

The FDA has approved PureTech Health’s ‘space occupying ... This would give it an edge on Novo’s obesity drug Saxenda (liraglutide), whose possible side effects include nausea, diarrhoea ...

The FDA recently approved Zepbound, a weekly injectable drug targeted to treat obesity. The medication contains tirzepatide, the same active ingredient that is also present in the diabetes drug ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Contrave label. U.S. Food and Drug Administration. Saxenda label. Novo Nordisk. Novo Nordisk receives FDA approval for Wegovy to treat adults with obesity based on unprescendented efficacy for a ...

Novo Nordisk is celebrating the FDA approval of its ... by Novo Nordisk as a daily pill called Rybelsus for diabetes, but that version isn't approved as an obesity treatment yet although a phase ...

The FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Rhythm Pharmaceuticals’ RYTM shares gained 8.4% on Aug. 26 after announcing the FDA ... new drug application (sNDA) for its only marketed drug, Imcivree (setmelanotide), to treat obesity ...

The U.S. Food and Drug Administration (FDA) approved the drug for weight control ... The drug has caused a lot of sensation as it attacks obesity. It was found that people on the drug ate less.

The U.S. Food and Drug Administration (FDA) has approved seven medications for ... Adults and children over 12 years old living with obesity are eligible to take this drug. Like Saxenda, you ...